MET inhibitor

MET receptor tyrosine kinase inhibitor

Blocks the MET receptor tyrosine kinase
Suppresses tumors with MET exon-14 skipping or amplification
Peripheral edema is the characteristic effect

Drugs with this mechanism (1)

Capmatinib — MET inhibitor for lung cancers with exon-14 skipping; photosensitivity and pneumonitis matter.

All mechanisms · Open the interactive console ↗